PRICE T ROWE ASSOCIATES INC /MD/ - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 104 filers reported holding MAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$59
-29.8%
18,797
+3.7%
0.00%
Q2 2023$84
+1.2%
18,123
+9.0%
0.00%
Q1 2023$830.0%16,629
+9.6%
0.00%
Q4 2022$83
-99.9%
15,174
+12.5%
0.00%
Q3 2022$88,000
-66.0%
13,493
-63.6%
0.00%
Q1 2022$259,000
-95.4%
37,018
-93.4%
0.00%
-100.0%
Q4 2021$5,674,000
-7.3%
556,816
+11.1%
0.00%0.0%
Q3 2021$6,121,000501,3220.00%
Other shareholders
MAXCYTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,885,000$5,881,2005.55%
Vitruvian Partners LLP 5,043,356$15,735,2714.46%
Stonepine Capital Management, LLC 3,761,640$11,736,3173.90%
Mudita Advisors LLP 1,390,858$4,339,4773.17%
RIVER GLOBAL INVESTORS LLP 1,473,254$4,588,3591.07%
Casdin Capital, LLC 1,890,000$5,896,8000.65%
Portolan Capital Management 2,143,666$6,688,2380.62%
Grandeur Peak Global Advisors, LLC 1,434,819$4,476,6350.34%
First Light Asset Management, LLC 1,073,110$3,348,1030.32%
Granahan Investment Management 1,975,847$6,164,6430.22%
View complete list of MAXCYTE INC shareholders